SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001078782-21-000445
Filing Date
2021-05-14
Accepted
2021-05-14 17:17:09
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-1 REGISTRATION STATEMENT s1051421_s1.htm S-1 1190143
2 EXHIBIT 5.1 LEGAL OPINION OF PROCOPIO, CORY, HARGREAVES & SAVITCH LLP s1051421_ex5z1.htm EX-5.1 10253
3 EXHIBIT 10.9 EQUITY PURCHASE AGREEMENT s1051421_ex10z9.htm EX-10.9 120579
4 EXHIBIT 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM s1051421_ex23z1.htm EX-23.1 2773
5 IMAGE s1051421ex5z1_1.jpg GRAPHIC 27913
6 IMAGE s1051421ex5z1_2.jpg GRAPHIC 20204
7 IMAGE s1051421s1_1.jpg GRAPHIC 38710
8 IMAGE s1051421s1_2.jpg GRAPHIC 98234
9 IMAGE s1051421s1_3.jpg GRAPHIC 361543
10 IMAGE s1051421s1_4.jpg GRAPHIC 323774
  Complete submission text file 0001078782-21-000445.txt   2521581
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-256162 | Film No.: 21926015
SIC: 2834 Pharmaceutical Preparations